News and Comments

ILMN AND HGSI: REASONS FOR ATYPICAL REJECTIONS OF TAKEOVERS

  Sunday, April 22, 2012

These days all the focus, the talk, the debates, and the confusion are, and will certainly continue for a while to be, about Illumina’s (ILMN) and Human Genome’s (HGSI) rejection of the acquisitions offers. The truth is that the offers were not as generous as they are said they are. More...

AFFYMAX vs. AMGEN?

  Tuesday, April 03, 2012

Affymax (AFFY) red blood growth factor drug Omontys (peginesatide) was granted FDA approval – good news for the firm. The approval is a remarkable achievement by Affymax. The firm has proven a capability developing biological products and there is no doubt that AFFY will sell the drug Omontys for patients with chronic kidney disease on dialysis, as it is dictated by the FDA.  More...


Recent Postings


Archive


Tags

Zerenex NOVOCURE (NVCR) Editas (EDIT) Sangamo (SGMO) CEMPRA (CEMP) SYNTA (SNTA) Human Genome Sciences (HGSI) Sanofi (SNA) Alnylam (ALNY) Intermune (ITMN) Prosensa (RNA) Jazz Pharmaceuticals (JAZZ) ImmunoGen (IMGN) Vertex (VRTX) TOKAI (TKAOI) Revlimid (lenolidamide) Trastuzumab-DM1 Roche (ROCHE) PTC Therapeutics (PTCT) OSI (OSIP) INNOVIVA (INVA) AGOS (ARGS) Bristol-Myers Squibb (BMY) Theravance Bio Pharma (TBPH) KERYX (KERX) Agenus (AGEN) RenenxBio (RGNX) Dynavax (DVAX) Velcade (bortezomib) Auspex (ASPX) Idenix (IDIX) GlaxoSmithKline (GSK) Vitae Pharmaceuticals (VTAE) Merck (MRK) Biocryst (BCRX) NEKTAR (NKTR)) CRISPR Therapeutics (CRSP) Exelixis (EXEL) ACADIA (ACAD) Roche (RHHBY) Prolor Biotech (PBTH) Spike Therapeutics (ONCE) Amgen (AMGN) SUNESIS PHARMACEUTICALS (SNSS) Tysabri C4 Therapeutics Aimmune Therapeutics (AIMT) Sanofi (SNY) Cytokinetics (CYTK) Benlysta (belimumab) Multiple Myeloma Abbott Laboratories (ABT) Genentech Pluristem (PSTI) Rapamune ADVENTRIX (ANX) ARCA (ABIO) Bellicum (BLCM) Human Longevity (HLI) ABBVIE (ABBV) Mirati Therapeutics (MRTX) Dendreon (DNDN) Micromet (MITI) Ionis (IONS) ZALTRAP™ Elan (ELN) KITE (KITE) Global Cell Therapeutics (GBT) AstraZeneca (AZN) Biogen Idec (BIIB) CompuGen (CGEN) Endometrial Cancer Sequenom (SQNM) Regeneron (REGN) NANTKWEST (NK) PORTOLA (PTLA) SERES THERAPEUTICS (MCRB) Galena (GALE) GUARDIAN HEALTH REGULUS (RGLS) Ariad (ARIA) Adaptimmune (ADAP) galapagos (GLPG) Intercept (ICPT) Alder Biopharmaceuticals (ALDR) Advaxis (ADXS) Onyx (ONXX) VANDA (VNDA) BIOMARIN (BMRN) JUNO (JUNO) AERIE PHARMACEUTICALS Xoma (XOMA) IDERA (IDRA) Inovio (INO) Agenus (AGEN Valeant Pharmaceuticals International (VRX) JOUNCE THERAPEUTICS (JNCE) Anacor (ANAC) Telaprevir Seattle Genetics (SGEN) ARGOS (ARGS) Gilead (GILD) Ocular Therapeutix (OCUL) Theravance (THRX) ISIS (ISIS) MODERNA Ridaforolimus Incyte (INCY) Herceptin Anadys (ANDS) Sarepta (SRPT) HALOZYME (HALO) Array Pharmaceuticals (ARRY) Ziofpharm (ZIOP) Illumina (ILMN) Intrexon (XON) Sanofi-Aventis (SAN)